Login

Insider Transactions

What Ra Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
New Enterprise Associates 13 Lp 10% owner Apr 02 Disposition to Issuer · D −6,135,234 — — 0
Ra Capital MANAGEMENT, L.p. Director Apr 02 Disposition to Issuer · D −4,858,260 $48.00 −$233M 0
Shah Rajeev M. Director Apr 02 Disposition to Issuer · D −4,858,260 $48.00 −$233M 0
Lubner David Charles Executive VP and CFO Apr 02 Disposition to Issuer · D −15,622 $48.00 −$750K 0
Treco Douglas A President and CEO Apr 02 Disposition to Issuer · D −234,707 $48.00 −$11.3M 0
Read Simon Chief Scientific Officer Apr 02 Disposition to Issuer · D −12,595 $48.00 −$605K 0
Ricardo Alonso See Remarks Apr 02 Disposition to Issuer · D −2,973 $48.00 −$143K 0
King John C Chief Commercial Officer Apr 02 Disposition to Issuer · D −10,823 $48.00 −$520K 0
Farzaneh-Far Ramin Chief Medical Officer Apr 02 Disposition to Issuer · D −14,492 $48.00 −$696K 0
Ricardo Alonso See Remarks Mar 17 Open-market sale · S −2,288 $44.25 −$101K 0
Farzaneh-Far Ramin Chief Medical Officer Mar 16 Open-market sale · S −10,595 $45.16 −$479K 7,132
Farzaneh-Far Ramin Chief Medical Officer Mar 16 Exercise / conversion · M +9,206 $5.60 +$51.6K 17,727
Farzaneh-Far Ramin Chief Medical Officer Mar 16 Exercise / conversion · M +1,389 $5.60 +$7.78K 8,521
Farzaneh-Far Ramin Chief Medical Officer Feb 18 Open-market sale · S −10,595 $46.61 −$494K 7,132
Farzaneh-Far Ramin Chief Medical Officer Feb 18 Exercise / conversion · M +9,206 $5.60 +$51.6K 17,727
Farzaneh-Far Ramin Chief Medical Officer Feb 18 Exercise / conversion · M +1,389 $5.60 +$7.78K 8,521
Ricardo Alonso See Remarks Jan 17 Open-market sale · S −2,285 $47.02 −$107K 2,288
Farzaneh-Far Ramin Chief Medical Officer Jan 15 Open-market sale · S −10,595 $46.95 −$497K 7,132
Farzaneh-Far Ramin Chief Medical Officer Jan 15 Exercise / conversion · M +9,206 $5.60 +$51.6K 17,727
Farzaneh-Far Ramin Chief Medical Officer Jan 15 Exercise / conversion · M +1,389 $5.60 +$7.78K 8,521

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support